Bios Partners — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Actuate Therapeuticsactuatetherapeutics.comin 𝕏NASDAQ: ACTUSep 2015SEC filinghigh confidence

Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.

BiotechFort Worth, US

Daniel Schmitt(Executive Officer, Director)Andrew Mazar(Executive Officer)Paul Lytle(Executive Officer)Leslie Wayne Kreis, Jr.(Director, Promoter)

BoardTodd Thomson(Director)Roger Sawhney(Director)

Board seatAaron G.L. FletcherLeslie W. Kreis, Jr.· per SEC Form D · $5M raise · filed Mar 2024

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.